原著論文
| 1 | Keita Koizumi Takahiro Domoto Toshinari Minamoto Kazuhito Satomura Hideo Nakajima. Deactivation of glycogen synthase kinase-3β by heat shock‑inducible tumor small protein attenuates hyperthermia‑induced pro‑migratory activity in colorectal cancer cells. Int J Oncol 63(2):2023. doi: 10.3892/ijo.2023.5540. [5.2] |  |
|---|---|---|
| 2 | Hiroko Ideo, Akiko Tsuchida, Yoshio Takada, Jun Kinoshita, Noriyuki Inaki, Toshinari Minamoto. Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells. Gastric Canser 26 (3): 352-363,2023. doi: 10.1007/s10120-023-01366-5 [7.701] |  |
| 3 | Yoko Matsuda , Juanjuan Ye , Keiko Yamakawa , Yuri Mukai , Kazuki Azuma , Linxuan Wu , Kenkichi Masutomi , Taro Yamashita , Yataro Daigo , Yohei Miyagi , Tomoyuki Yokose , Takashi Oshima , Hiroyuki Ito , Soichiro Morinaga , Takeshi Kishida , Toshinari Minamoto , Motohiro Kojima , Shuichi Kaneko , Reiji Haba , Keiichi Kontani , Nobuhiro Kanaji , Keiichi Okano , Mariko Muto-Ishizuka , Masanao Yokohira , Kousuke Saoo , Katsumi Imaida , Futoshi Suizu. Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis. JNCI115(2):208-218,2023. doi: 10.1093/jnci/djac226 [11.816] |  |
| 4 | Chau P Tran , Michelle Scurr , Louise O'Connor , Jon N Buzzelli , Garrett Z Ng , Sharleen Chung Nien Chin , Lincon A Stamp , Toshinari Minamoto , Andrew S Giraud , Louise M Judd , Philip Sutton , Trevelyan R Menheniott. IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells. Oncotarget1;13:785-799,2022. doi: 10.18632/oncotarget.28238 [0.966] |  |
| 5 | Kondo H, Mishiro K, Iwashima Y, Qiu Y, Kobayashi A, Lim K, Domoto T, Minamoto T, Ogawa K, Kunishima M, Hazawa M, Wong, RW. Discovery of a novel aminocyclopropenone compound that inhibits BRD4-driven nucleoporin NUP210 expression and attenuates colorectal cancer growth. Cells 11 (3): 317, 2022. doi: 10.3390/cells11030317 [6.600] |  |
| 6 | Shimasaki T, Yamamoto S, Omura R, Ito K, Nishide Y, Yamada H4, Ohtomo K, Ishisaka T, Okano K, Ogawa T, Tsuji H, Matsuo Y, Minamoto T, Tomosugi N, Ferain E, Ochiya T. Novel platform for regulation of extracellular vesicles and metabolites secretion from cells using a multi-linkable horizontal co-culture plate. Micromachines 12 (11): 1431, 2021. doi: 10.3390/mi12111431 [2.523] |  |
| 7 | Kotake M, Bando H, Kaneko M, Takemura H, Minamoto T, Kawakami K. LOH of the thymidylate synthase locus in combination with genotype has prognostic and predictive significance in colorectal cancer. Mol Clin Oncol 15 (5): 235, 2021. doi: 10.3892/mco.2398. [1.500] |  |
| 8 | Uehara M, Domoto T, Takenaka S, Bolidong D, Takeuchi O, Miyashita T, Minamoto T. Glycogen synthase kinase 3β participates in acquired resistance to gemcitabine in pancreatic cancer. Cancer Sci 111 (12): 4405-4416,2020. doi: 10.1111/cas.14668 [6.716] |  |
| 9 | Ota R, Sawada T, Tsuyama S, Yao T, Sasaki Y, Suzuki H, Kaizaki Y, Hasatani K, Yamamoto E, Nakanishi H, Inagaki S, Tsuji S, Yoshida N, Doyama H, Kasashima S, Kubota E, Kataoka H, Tokino T, Minamoto T. Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas. J Pathol 252 (3): 330-42,2020. doi: 10.1002/path.5529. [7.996] |  |
| 10 | Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma. Sci Rep 10 (1): 11807, 2020. doi: 10.1038/s41598-020-68713-9. [4.379] |  |
| 11 | Chung Nien Chin S, O’Connor L, Scurr M, Busada JT, Graham AN, Alipour Talesh G, Tran CP, Sarkar S, Minamoto T, Giraud AS, Cidlowski JA, Sutton P, Menheniott TR. Coordinated expression loss of GKN1 and GKN2 in gastric cancer via impairment of a glucocorticoid-responsive enhancer. Am J Physiol Gastrointest Liver Physiol 319 (2): G175-G188, 2020. doi: 10.1152/ajpgi.00019.2020. [3.725] |  |
| 12 | Nakanishi H, Sawada T, Kaizaki Y, Suzuki H, Yamamoto E, Ota R, Aoki H, Eizuka M, Hasatani K, Takahashi N, Kuno T, Inagaki S, Yamada S, Ebi M, Kubota E, Kataoka H, Takahashi S, Minamoto T1, Tokino T, Sugai T, Sasaki Y. Significance of gene mutations in Wnt signaling pathway in traditional serrated adenomas of the colon and rectum. PLoS ONE 15 (2): e0229262, 2020. doi: 10.1371/journal.pone.0229262. [3.240] |  |
| 13 | Ailiken G, Kitamura K, Hoshino T, Satoh M, Tanaka N, Minamoto T, Rahmutulla B, Kobayashi S, Kano M, Tanaka T, Kaneda A, Nomura F, Matsubara H, Matsushita K. Posttranscriptional regulation of BRG1 by FIRΔexon2 in gastric cancer. Oncogenesis 9 (2): 26, 2020. doi: 10.1038/s41389-020-0205-4. [7.485] |  |
| 14 | Abe K*, Yamamoto N, Domoto T*, Bolidong D, Hayashi K, Takeuchi A, Miwa S, Inatani H, Aoki Y, Higuchi T, Taniguchi Y, Yonezawa H, Aiba H, Araki Y, Minamoto T, Tsuchiya H. Glycogen synthase kinase 3β as a potential therapeutic target in synovial and fibrosarcoma. Cancer Sci 111 (2): 429-40, 2020. doi: 10.1111/cas.14271. [Epub ahead of print] [6.716] |  |
| 15 | Kitabayashi T, Dong Y, Furuta T, Sabit H, Jiapaer S, Jiakang Z, Guangtao Z, Hayashi Y, Kobayashi M, Domoto T, Minamoto T, Hirao A, Nakada M. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma. Sci Rep 9 (1): 10049, 2019. doi: 10.1038/s41598-019-46454-8.[4.379] | |
| 16 | Kobayashi S, Hiwasa T, Ishige T, Rahmutulla B, Kano M, Hoshino T, Minamoto T, Shimada H, Nomura F, Matsubara H, Matsushita K. Anti-FIRΔexon2, a splicing variant form of PFU60, autoantibody is detected in the sera of esophageal squamous cell carcinoma. Cancer Sci 110 (6): 2004-13, 2019. doi: 10.1111/cas.14024. Epub 2019 May 20. [6.716] |  |
| 17 | Echizen K, Horiuchi K, Aoki Y, Yamada Y, Minamoto T, Oshima H, Oshima M. NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells. Oncogene 38 (22): 4250-63, 2019. doi: 10.1038/s41388-019-0702-0. Epub 2019 Jan 30. [9.867] |  |
| 18 | Han TS, Voon DCC, Oshima H, Makayama M, Echizen K, Sakai E, Murakami K, Yu L, Minamoto T, Jenkins BJ, Yang HK, Oshima M. MicroRNA-135b acts downstream of interleukin-1 signaling during inflammation-associated gastric carcinogenesis. Gastroenterology 156 (4): 1140-55.e4, 2019. doi: 10.1053/j.gastro.2018.11.059. Epub 2018 Nov 30. [22.682] |  |
| 19 | Kitamura H, Takemura H, Minamoto T. Tumor p16INK4 gene expression and prognosis
in colorectal cancer. Oncol Rep 41(2): 1367-76, 2019. doi: 10.3892/or.2018.6884.
Epub 2018 Nov 26. [3.906] |
 |
| 20 | Dewi FRP, Domoto T, Hazawa M, Kobayashi A, Douwaki T, Minamoto T, Wong RW. Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promotor region (Tpr)-dynein interaction. Oncotarget 9 (17): 13337-52, 2018. doi: 10.18632/oncotarget.24344. [5.168] |  |
| 21 | Kimura A, Kitamura K, Ailiken G, Satoh M, Minamoto T, Tanaka N, Nomura F, Matsushita K. FIR haplodeficiency promotes splicing to pyruvate kinase M2 in mice thymic lymphoma tissues using six-plex tandem mas tag quantitative proteomic analysis. Oncotarget 8 (40): 67955-65, 2017. doi: 10.18632/oncotarget.19061. [5.168] |  |
| 22 | Mohamed MS, Kobayashi A, Taoka A, Watanabe-Nakayama T, Kikuchi Y, Hazawa M, Minamoto T, Fukumori Y, Kodera N, Uchihashi T, Ando T, Wong RW. High-speed atomic force microscopy reveals loss of nuclear pore resilience as a dying code in colorectal cancer cells. ACS Nano 11 (6): 5567-78, 2017 Jun 27. doi: 10.1021/ acsnano.7b00906. Epub 2017 May 31. [15.881] |  |
| 23 | Furuta T, Sabit H, Dong Y, Miyashita K, Kinoshita M, Uchiyama N, Hayashi Y, Hayashi Y, Minamoto T, Nakada M. Biological basis and clinical study of glycogen synthase kinase-3β-targeted therapy by drug repositioning for glioblastoma. Oncotarget 8 (14): 22811-24, 2017. doi: 10.18632/oncotarget.15206 [5.168] |  |
| 24 | Matsuda Y, Ishiwata T, Yoshimura H, Yamahatsu K, Minamoto T, Arai T. Nestin phosphorylation at threonines 315 and 1299 correlates with proliferation and metastasis of human pancreatic cancer. Cancer Sci 108 (3): 354-61, 2017. doi: 10.1111/cas.13139. Epub ahead of print. [6.716] |  |
| 25 | Kaneko M , Kotake M, Bando H, Yamada T, Takemura H, Minamoto T. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer. BMC Cancer 16:945,2016 Dec. 12. doi: 10.1186/s12885-016-2984-8 [4.430] |
 |
| 26 | Shimozaki S, Yamamoto N, Domoto T, Nishida H, Hayashi K, Kimura H, Takeuchi A, Miwa S, Igarashi K, Kato T, Aoki Y, Higuchi T, Hirose M, Hoffman RM, Minamoto T, Tsuchiya H. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin. Oncotarget 47 (7): 77038-51, 2016. doi:10.18632/oncotarget.12781 [5.168] |  |
| 27 | Menheniott TR, O'Connor L, Chionh YT, Däbritz J, Scurr M, Rollo BN, Ng GZ, Jacobs S, Catubig A, Kurklu B, Mercer S, Minamoto T, Ong DE, Ferrero RL, Fox JG, Wang TC, Sutton P, Judd LM, Giraud AS. Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression. J Clin Invest 126 (4):1383-400, 2016. doi:10.1172/JCI82655. Epub 2016 Mar 14. [14.808] |  |
| 28 | Chikano Y, Domoto T, Furuta T, Sabit H, Kitano-Tamura A, Pyko IV, Takino T, Sai Y, Hayashi Y, Sato H, Miyamoto KI, Nakada M, Minamoto T. Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1 and c-Jun N-terminal kinase-mediated pathway. Mol Cancer Ther 14 (2): 564-74, 2015. [6.261] |  |
| 29 | Kurklu B, Whitehead RH, Ong EK, Minamoto T, Fox JG, Mann JR, Judd LM, Giraud AS, Menheniott TR. Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer. Oncogene, 34 (22): 2856-66, 2015. doi: 10.1038/onc.2014. 233. [Epub ahead of print] [9.867] |  |
| 30 | Oshima H, Ishikawa T, Yoshida GJ, Naoi K, Maeda Y, Naka K, Ju X, Yamada Y, Minamoto T, Mukaida N, Saya H, Oshima M. TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells. Oncogene 33 (29): 3820-9, 2014. doi: 10.1038/onc.2013.356. Epub 2013 Aug 26. [9.867] | |
| 31 | Suzuki R, Yamamoto H, Ngan CY, Ohtsuka M, Kitani K, Uemura M, Nishimura J, Takemasa I, Mizushima T, Sekimoto M, Minamoto T, Doki Y, Mori M. Inhibition of angiopoietin 2 attenuates lumen formation of tumour-associated vessels in vivo. Int J Oncol 43 (5): 1447-55, 2013. doi: 10.3892/ijo.2013.2076. Epub 2013 Aug 23. [5.650] |  |
| 32 | Pyko IV, Nakada M, Sabit H, Lei T, Furuyama N, Hayashi Y, Kawakami K, Minamoto T, Fedlau AS, Hamada JI. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling. Carcinogenesis 34 (10): 2206-17, 2013. doi: 10.1093/carcin/bgt182. Epub 2013 May 28. [4.944] | |
| 33 | Kitano A, Shimasaki T, Chikano Y, Nakada M, Hirose M, Higashi T, Ishigaki Y, Endo Y, Takino T, Sato H, Sai Y, Miyamoto KI, Motoo Y, Kawakami K, Minamoto T. Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy. PLoS One 8 (2): e55289, 2013. doi:10.1371/journal.pone.0055289. Epub 2013 Feb 8. [3.240] | |
| 34 | Loh M, Chua D, Yao Y, Soo RA, Zeps N, Platell C, Kawakami K, Minamoto T, Iacopetta B, Soong R. Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies? Pharmacogenomics J 13 (5): 423-9, 2013. doi: 10.1038/tpj.2012.26. Epub 2012 Jun 26. [3.550] |  |
| 35 | Matsunoki A, Kawakami K, Kotake M, Kaneko M, Kitamura H, Ooi A, Watanabe G, Minamoto T. LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer. BMC Cancer 12: 574, 2012. doi: 10.1186/1471-2407-12-574. [4.430] |  |
| 36 | Nakajima H, Koizumi K, Tanaka T, Ishigaki Y, Yoshitake Y, Yonekura H, Sakuma T, Fukushima T, Umehara H, Ueno S, Minamoto T, Motoo Y. Loss of HITS (FAM107B) expression in cancer of the multiple organs: a tissue microarray analysis. Int J Oncol 41 (4): 1347-57. 2012. doi: 10.3892/ijo.2012.1550. Epub 2012 Jul 10. [5.650] |  |
| 37 | Kong D, Piao YS, Oshima H, Oguma K, Minamoto T, Yamada Y, Sato K, Yamashita S, Ushijima T, Ishikawa T, Oshima M. Inflammation-induced repression of tumor suppressor miR-7 in gastric epithelial cells. Oncogene 31 (35): 3949-3960, 2012. doi: 10.1038/onc.2011.558. Epub 2011 Dec 5. [9.867] | |
| 38 | Shimasaki T, Ishigaki Y, Nakamura Y, Takata T, Nakaya N, Nakajima H, Sato I, Zhao X, Kitano A, Kawakami K, Tanaka T, Takegami T, Tomosugi N, Minamoto T, Motoo Y. Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. J Gastroenterol 47 (3): 321-333, 2012. doi: 10.1007/s00535-011-0484-9. Epub 2011 Nov 1. [7.527] |  |
| 39+ | Mimura M, Masuda A, Nishiumi S, Kawakami K, Fujishima Y, Yoshie T, Mizuno S, Miki I, Ohno H, Hase K, Minamoto T, Azuma T, Yoshida M. AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene. Int J Cancer 130 (5): 1011-1020, 2012. doi: 10.1002/ijc.26131. Epub 2011 May 30. [7.396] |  |
| 36 | Tomita H, Takaishi S, Menheniott TR, Yang X, Shibata W, Jin G, Betz KS, Kawakami K, Minamoto T, Tomasetto C, Rio MC, Lerkowit N, Varro A, Giraud AS, Wang TC. Inhibition of gastric carcinogenesis by the hormone, gastrin, is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology 140 (3): 879-891, 2011. doi:10.1053/j.gastro.2010.11.037. Epub 2010 Nov 25. [22.682] |  |
| 37 | Kawakami K, Matsunoki A, Kaneko M, Saito K, Watanabe G, Minamoto T. Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer. Cancer Sci 102 (1): 166-174, 2011. doi: 10.1111/j.1349-7006.2010.01776.x. Epub 2010 Nov 19. [6.716] |  |
| 38 | Peterson AJ, Menheniott TR, O'Connor L, Walduck AK, Fox JG, Kawakami K, Minamoto T, Ong EK, Wang TC, Judd LM, Giraud AS. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Gastroenterology 139 (6): 2005-2017, 2010. DOI:10.1053/j.gastro.2010.08.043. Epub 2010 Aug 27. [22.682] |  |
| 39 | Nakajima H, Ishigaki Y, Xia Q, Ikeda T, Yoshitake Y, Yonekura H, Nojima T, Tanaka T, Umehara H, Tomosugi N, Takata T, Shimasaki T, Nakaya N, Sato I, Kawakami K, Koizumi K, Minamoto T, Motoo Y. Induction of HITS, a newly identified family with sequence similarity 107 protein (FAM107B), in cancer cells by heat shock stimulation. Int J Oncol 37 (3): 583-593, 2010. [5.650] |  |
| 40 | Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T. Long inter-spersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non–small cell lung cancer. Clin Cancer Res 16 (8): 2418-2426, 2010. doi: 10.1158/1078-0432.CCR-09-2819. Epub 2010 Apr 6. [12.531] |  |
| 41 | Jin MJ, Kawakami K, Fukui Y, Tsukioka S, Oda M, Watanabe G, Takechi T, Oka T, Minamoto T. Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels. Cancer Sci 100 (12): 2325-2330, 2009. doi: 10.1111/j.1349-7006.2009.01321.x. Epub 2009 Aug 25. [6.716] |  |
| 42 | Mai W, Kawakami K, Shakoori A, Kyo S, Miyashita K, Yokoi K, Jin MJ, Shimasaki T, Motoo Y, Minamoto T. Deregulated glycogen synthase kinase 3β sustains gastro-intestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase. Clin Cancer Res 15 (22): 6810-6819, 2009. DOI:10.1158/1078-0432.CCR-09-0973. Epub 2009 Nov 10. [12.531] |  |
| 43 | Noubissi FK, Sanek NA, Kawakami K, Minamoto T, Moser A, Grinblat Y, Spiegelman VS. Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. Cancer Res 69 (22): 8572-8578, 2009. doi: 10.1158/0008-5472.CAN-09-1500. Epub 2009 Nov 3. [12.701] |  |
| 44 | Du YC, Oshima H, Oguma K, Kitamura T, Itadani H, Fujimura T, Piao YS, Yoshimoto T, Minamoto T, Kotani H, Taketo MM, Oshima M. Induction and downregulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis. Gastroenterology 137 (4): 1346-1357, 2009. doi: 10.1053/j.gastro.2009.06.041. Epub 2009 Jun 21. [22.682] |  |
| 45 | Miyashita K, Kawakami K, Mai W, Shakoori A, Fujisawa H, Nakada M, Hayashi Y, Hamada J, Minamoto T. Potential therapeutic effect of glycogen synthase kinase 3β inhibition against human glioblastoma. Clin Cancer Res 15 (3): 887-897, 2009. doi: 10.1158/1078-0432.CCR-08-0760. [12.531] |  |
| 46 | Howlett M, Giraud AS, Lescesen H, Jackson CB, Kalantzis A, van Driel IR, Robb L, Van der Hoek M, Ernst M, Minamoto T, Boussioutas A, Oshima H, Oshima M, Judd LM. The IL-6 family cytokine IL-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development. Gastroenterology 136 (3): 967-977, 2009. doi: 10.1053/j.gastro.2008.12.003. Epub 2008 Dec 3. [22.682] |  |
| 47 | Ohno S, Kinoshita T, Ohno Y, Minamoto T, Suzuki N, Inoue M, Suda T. Expression of NLRP7 (PYPAF3, NALP7)protein in endometrial cancer tissues. Anticancer Res 28 (4C): 2493-2497, 2008. [2.480] |  |
| 48 | Kawakami K, Ooyama A, Ruszkiewicz A, Jin M, Watanabe G, Moore J, Oka T, Iacopetta B, Minamoto T. Low expression of γ-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype. Brit J Cancer 98 (9): 1555-1561. doi: 10.1038/sj.bjc.6604346. Epub 2008 Apr 15. [7.640] |  |
| 49 | Mai W, Miyashita K, Shakoori A, Zhang B, Yu ZW, Takahashi Y, Motoo Y, Kawakami K, Minamoto T. Detection of active fraction of GSK3β in cancer cells by nonradioiso-topic in vitro kinase assay. Oncology 71 (3-4): 297-305, 2006 (published in July 23, 2007). [2.935] |  |
| 50 | Iacopetta B, Grieu F, Phillips M, Ruszkiewicz A, Moore J, Minamoto T, Kawakami K. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 98 (9): 1454-1460, 2007. Epub 2007 Jul 19. [6.716] |  |
| 51 | Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, Kawakami K, Minamoto T. Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 98 (9): 1388-1393, 2007. Epub 2007 Jul 19. [6.716] |  |
| 52 | Yamashita K, Ougolkov A, Nakazato H, Ito K, Ohashi Y, Kitakata H, Yasumoto K, Omote K, Mai M, Takahashi Y, Minamoto T. Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic β-catenin activation. Dis Colon Rectum 50 (8): 1169-1181, 2007. Erratum in: Dis Colon Rectum. 2007 Aug;50(8):1182-7. [4.585] |  |
| 53 | Noubissi F, Elcheva I, Bhatia N, Shakoori A, Ougolkov A, Liu J, Minamoto T, Ross J, Fuchs SY, Spiegelman VS. CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signaling. Nature 441 (7095): 898-901, 2006. [49.962] |  |
| 54 | Jiang PH, Motoo Y, Sawabu N, Minamoto T. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells. World J Gastroenterol 12 (10): 1597- 1602, 2006. [5.742] |  |
| 55 | Maenaka S, Hikichi T, Imai-Akasofu M, Minamoto T, Kawahara E. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection. Oncol Rep 15 (4): 791-795, 2006. [3.906] |  |
| 56 | Kamakura Y, Hasegawa M, Kida S, Tachibana O, Okamoto Y, Minamoto T, Yamashita J, Fujisawa H. c-kit gene mutation is common and widely distributed in intracranial germinomas. J Neurosurg (3 Suppl Pediatrics) 104: 173-180, 2006. [5.115] |  |
| 57 | Zenda T, Masunaga T, Shinozaki K, Hashiba A, Fuwa B, Okada T, Minamoto T, Minato H. Primary minute invasive de novo colonic adenocarcinoma appearing as submucosal tumor. Int J Gastrointest Cancer 36 (3): 177-181, 2005.[NA] |  |
| 58 | Aoki M, Yamamoto K, Ohyama S, Yamamura Y, Takenoshita S, Sugano K, Minamoto T, Kitajima M, Sugimura H, Shimada S, Noshiro H, Hiratsuka M, Sairenji M, Ninomiya I, Yano M, Uesaka K, Matsuno S, Maehara Y, Aikou T, Sasazuki T. A genetic variant in the gene encoding the stress 70 protein chaperone family member STCH is associated with gastric cancer in the Japanese population. Biochem Biophys Res Commun 335 (2): 566-574, 2005. [3.575] |  |
| 59 | Shakoori A, Ougolkov A, Yu ZW, Zhang B, Modarressi MH, Billadeau DD, Mai M, Takahashi Y, Minamoto T. Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun 334 (4): 1365-1373, 2005. [3.575] |  |
| 60 | Kawahara E, Saito A, Kobayashi J, Maenaka S, Minamoto T, Akasofu-Imai M, Oda Y. Adhesiveness of β5 integrin variant lacking FNK767-769 is similar to that of the prototype containing FNKFNK767-769. Cell Biol Int 29 (7): 521-528, 2005. [3.612] |  |
| 61 | Misaki K, Marukawa K, Hayashi Y, Fukusato T, Minamoto T, Hasegawa M, Yamashita J, Fujisawa H. Correlation of γ-catenin expression with good prognosis in medullo-blastomas. J Neurosurg (Pediatrics 2) 102: 197-206, 2005. [5.115] |  |
| 62 | Aoki M, Yamamura Y, Noshiro H, Sakai K, Yokota J, Kohno T, Tokino T, Ishida S, Ohyama S, Ninomiya I, Uesaka K, Kitajima M, Shimada S, Matsuno S, Yano M, Hiratsuka M, Sugimura H, Itoh F, Minamoto T, Maehara Y, Takenoshita S, Aikou T, Katai H, Yoshimura K, Takahashi T, Akagi K, Sairenji M, Yamamoto K, Sasazuki T. A full genome scan for gastric cancer. J Med Genet 42 (1): 83-87, 2005. [6.318] |  |
| 63 | Ougolkov A, Zhang B, Yamashita K, Bilim V, Mai M, Fuchs SY, Minamoto T. Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin and NF-kB in colorectal cancer. J Natl Cancer Inst 96 (15): 1161-1170, 2004. [13.757] |  |
| 64 | Watanabe H, Yamaguchi Y, Ohtsubo K, Mouri H, Motoo Y, Yamashita K, Minamoto T, Gabata T, Sawabu N. Epidermoid cyst of the intrapancreatic accessory spleen producing CA19-9. Digest Endosc 16 (3): 244-248, 2004. [7.559] |  |
| 65 | Takahashi Y, Kitakata H, Yamashita K, Yasumoto K, Omote K, Minamoto T, Mai M. Pilot study of low dose, divided maximum tolerated dose of CPT-11 in 21 consecutive patients with metastatic colorectal or gastric cancer. Surg Today 34 (3): 246-250, 2004. [2.549] |  |
| 66 | Zhang B, Ougolkov A, Yamashita K, Takahashi Y, Mai M, Minamoto T. β-catenin and ras oncogenes detect most human colorectal cancers. Clin Cancer Res 9 (8): 3073-3079, 2003. [12.531] |  |
| 67 | Kawashima A, TsugawaS, Boku A, Kobayashi M, Minamoto T, Nakanishi I, Oda Y. Expression of av integrin family in gastric carcinomas: increased αvb6 is associated with lymph node metastasis. Pathol Res Prac 199 (2): 57-64 2003. [3.250] |  |
| 68 | Okai T, Minamoto T, Ohtsubo K, Minato H, Kurumaya H, Oda Y, Mai M, Sawabu N. Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor. Abdom Imaging 28 (3): 301-307, 2003. [2.443] |  |
| 69 | Morita H, Hasegawa T, Minamoto T, Oda Y, Inui K, Tayama H, Nakao N, Ideura T, Yoshimura A. Collagenofibrotic glomerulopathy with a widespread expression of type V collagen. Virchow's Archiv 442 (2): 163-168, 2003. [4.064] |  |
| 70 | Sabet EA, Okai T, Minamoto T, Mai M, Sawabu N. Visualizing the gastric wall with a 30-MHz ultrasonic miniprobe: ex vivo imaging of normal gastric sites and sites of early gastric cancer. Abdom Imaging 28 (2): 252-256, 2003. [2.443] |  |
| 71 | Ougolkov A, Yamashita K, Bilim V, Takahashi Y, Mai M, Minamoto T. Abnormal expression of E-cadherin, β-catenin and c-erbB-2 in gastric cancer with liver metastasis. Int J Colorect Dis (Clin Mol Gastroenterol Surg) 18 (2): 160-166, 2003. [2.571] |  |
| 72 | Sabet EA, Okai T, Minamoto T, Mai M, Sawabu N. Three-dimensional endoscopic ultrasonography for the assessment of gastric carcinoma invasion: could it provide diagnostic innovations? Digest Endosc 14: 53-60, 2002. [7.559] |  |
| 73 | Hirano K, Yamashita N, Ohta T, Yamashita K, Nakazumi Y, Esumi H, Kawashima A, Mai M, Minamoto T. Non-Hodgkin lymphoma in a patient with probable hereditary non-polyposis colorectal cancer. Report of a case and review of the literature. Dis Colon Rectum 45 (2): 273-279, 2002. [4.585] |  |
| 74 | Ougolkov AV, Yamashita K, Mai M, Minamoto T. Oncogenic β-catenin and MMP-7 (matrilysin) cosegregate in the late-stage clinical colon cancer. Gastroenterology 122 (1): 60-71, 2002. [22.682] |  |
| 75 | Minamoto T, Buschmann T, Habelhah H, Matusevich E, Tahara H, Boerresen-Dale A-L, Harris C, Ronai Z. Distinct pattern of p53 phosphorylation in human tumors. Oncogene 20 (26): 3341-3347, 2001. [9.867] |  |
| 76 | Buschman T, Ivanov VN, Henderson S, Fried VA, Minamoto T, Alarcon-Vargas D, Pincus MR, Fuchs SY, Ronai Z. JNK phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Cell Biol 21 (8): 2743-2754, 2001. [4.272] |  |
| 77 | Sabet EA, Okai T, Minamoto T, Sawabu N. Endosonographic features of advanced gastric carcinoma invading the colon: is it easy to differentiate from pancreatic invasion? Endoscopy 33 (2): 197, 2001. [10.093] |  |
| 78 | Okai T, Minamoto T, Ohtsubo K, Takahashi Y, Kitagata H, Kadoya M, Oda Y, Sawabu N. Presacral ganglioneuroma arising in an elderly man with constipation. Abdominal Imaging 26 (2): 215-217, 2001. [2.443] | |
| 79 | Hirano K, Minamoto T. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinomas of colon and rectum – a comparative clinicopathologic and molecular analysis. Cancer Detect Prev (Cancer Epidemiol) 24 (4): 343- 355, 2000. [2.522] |  |
| 80 | Ougolkov A, Mai M, Takahashi Y, Bilim V, Shimizu A, Minamoto T. Altered expression of β-catenin and c-erbB-2 in early gastric cancer. J Exp Clin Cancer Res 19 (3): 349-355, 2000. [11.161] |  |
| 81 | Spiegelman VS, Slaga TJ, Pagano M, Minamoto T, Ronai Z, Fuchs SY. Wnt/β-catenin signaling induces the expression and activity of βTrCP ubiquitin ligase receptor. Mol Cell 5 (5): 877-882, 2000. [17.970] |  |
| 82 | Buschmann T, Minamoto T, Wagle N, Fuchs SY, Adler V, Mai M, Ronai Z. Analysis of JNK, Mdm2 and p14ARF contribution to the regulation of mutant p53 stability. J Mol Biol 295 (4): 1009-1021, 2000. [5.469] |  |
| 83 | Kigasawa K, Ishikawa H, Obazawa H, Minamoto T, Nagai Y, Tanaka Y. Collagen production by cultured human retinal pigment epithelial cells. Tokai J Exp Clin Med 23 (3): 147-151, 1998.[0.185] |  |
| 84 | Ronai Z, Minamoto T. Quantitative Enriched PCR (QEPCR), a highly sensitive method for detection of K-ras oncogene mutation. Hum Mutat 10 (4): 322-325, 1997. [4.878] |  |
| 85 | Sory A, Minamoto T, Ohta T, Yamashita K, Sawaguchi K, Mai M, Misiuna P. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma? Eur J Surg 163 (9): 685-692, 1997. [0.782] |  |
| 86 | Minamoto T, Esumi H, Ochiai A, Belitsky G, Mai M, Sugimura T, Ronai Z. Combined analysis of microsatellite instability and K-ras mutation increases detection incidence of normal and tumor samples from colorectal cancer patients. Clin Cancer Res 3 (8): 1413- 1417, 1997. [12.531] |  |
| 87 | Adler V, Pincus MR, Minamoto T, Fuchs SY, Bluth MJ, Brandt-Rauf PW, Friedman F, Chen JM, Wang XW, Harris CC, Ronai Z. Conformation-dependent phosphorylation of p53. Proc Natl Acad Sci USA 94 (5): 1686-1691, 1997. [11.205] |  |
| 88 | Motoo Y, Minamoto T, Watanabe H, Sakai J, Okai T, Sawabu N. Sclerosing pancreatitis showing repidly progressive changes with recurrent mass formation. Int J Pancreatol 21 (1): 85-90, 1997. [1.542] |  |
| 89 | Sory A, Minamoto T, Ohta T, Yamashita K, Sawaguchi K, Mai M, Misiuna P. Is p53 overexpression the risk factor for metastases in early invasive colorectal carcinoma? GI Cancer 2: 119-127, 1997.[0.513] |  |
| 90 | Minamoto T, Yamashita N, Ochiai A, Sugimura T, Mai M, Ronai Z, Esumi H. Analysis of mutant K-ras in multiple sites of normal appearing mucosa of colorectal cancer patients. Int J Oncol 9: 911-915, 1996. [3.899] |  |
| 91 | Ronai Z, Minamoto T, Butler R, Tobi M, Luo FQ, Zang E, Esumi H, Sugimura T. Sampling method as key factor in identifying K-ras oncogene mutations in pre-neoplastic colorectal lesions. Cancer Detec Prev (Cancer Epidemiol) 19 (6): 512-513, 1995. [2.179] |  |
| 92 | Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: Is there preference among K-ras mutations for malignant progression? Cancer 75 (6): 1527-1533, 1995. [5.472] |  |
| 93 | Minamoto T, Yamashita N, Ochiai A, Sugimura T, Mai M, Ronai Z, Esumi H. Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a bio-marker of colorectal tumorigenesis. Cancer 75 (6): 1520-1526, 1995. [5.472] |  |
| 94 | Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of colon. Gastroenterology 108 (2): 434-440, 1995. [22.682] |  |
| 95 | Takahashi M, Minamoto T, Yamashita N, Kato T, Yazawa K, Sugimura T, Esumi H. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Lett 83 (1-2): 177-184, 1994. [8.679] |  |
| 96 | Yamashita N, Minamoto T, Onda M, Esumi H. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn J Cancer Res (Cancer Sci) 85 (7): 692-698, 1994. [6.716] |  |
| 967 | Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 54 (11): 2841-2844, 1994. [12.701] |  |
| 98 | Minamoto T, Sawaguchi K, Ohta T, Itoh T, Mai M. Superficial-type adenomas and adenocarcinomas of the colon and rectum. A comparative morphologic study. Gastroenterology 106 (6): 1436-1443, 1994. [22.682] |  |
| 99 | Minamoto T, Kitagawa M, Amano N, Tsukada Y, Hirose T, Mai M. Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile. J Surg Oncol 55 (4): 215-221, 1994. [3.454] |  |
| 100 | Minamoto T, Ronai Z, Yamashita N, Ochiai A, Sugimura T, Mai M, Esumi H. Detection of K-ras mutation in non-neoplastic mucosa of Japanese patients with colorectal cancers. Int J Oncol 4 (2): 397-401, 1994. [5.650] |  |
| 101 | Takahashi M, Minamoto T, Sugimura T, Esumi H. High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo [4,5-f]quinoline. Carcinogenesis 14 (7): 1355-1357, 1993. [4.944] |  |
| 102 | Minamoto T, Mai M, Ogino T, Sawaguchi K, Ohta T, Fujimoto T, Takahashi Y. Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development. Am J Gastroenterol 88 (7): 1035-1039, 1993. [10.171] |  |
| 103 | Takahashi M, Minamoto T, Yamashita N, Yazawa K, Sugimura T, Esumi H. Reduction in formation and growth of 1,2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid. Cancer Res 53 (12): 2786-2789, 1993. [12.701] | |
| 104 | Motoo Y, Sawabu N, Minamoto T, Kawakami H, Ohta H, Okai T, Fujimoto T, Mai M, Matsui O, Nakanishi I, Nakanuma Y. Rapidly growing mucinous cholangiocarcinoma. Int Med 32 (2): 116-121, 1993. [1.271] |  |
| 105 | Katsuda S, Okada Y, Minamoto T, Oda Y, Matsui Y, Nakanishi I. Collagen in human atherosclerosis. Immunohistochemical analysis using collagen-type specific antibodies. Arteriosc Thromb (Arterioscl Throm Vasc Biol) 12 (4): 494-502, 1992. [6.604] |  |
| 106 | Minamoto T, Ueda H, Ooi A, Omote K, Ogino T, Mai M. A limitation of endoscopic ultrasound: An unusual case of early gastric cancer overlying a pancreatic rest. Am J Gastroenterol 86 (5): 622-626, 1991. [10.171] |  |
| 107 | Ohta T, Mai M, Ogino T, Kida Y, Minamoto T, Takahashi Y, Sawaguchi K, Jinkawa S, Yasuda Y. Minute rectal cancer associated with nodular involvement -A case study-. Dig Endosc 3: 90-94, 1991. [7.599] |  |
| 108 | Minamoto T, Sawaguchi K, Ogino T, Mai M. Anisakiasis of the colon: Report of two cases with emphasis on the diagnostic and therapeutic value of colonoscopy. Endoscopy 23 (1): 50-52, 1991. [10.093] |  |
| 109 | Okada Y, Naka K, Minamoto T, Ueda Y, Oda Y, Nakanishi I, Timple R. Localization of type VI collagen in the lining cell layer of normal and rheumatoid synovium. Lab Invest 63 (5): 647-656, 1990. [5.662] |  |
| 110 | Minamoto T, Mai M, Watanabe K, Ooi A, Kitamura T, Takahashi Y, Ueda H, Ogino T, Nakanishi I. Medullary carcinoma with lymphocytic infiltration of the stomach. Clinico-pathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in the tumor. Cancer 66 (5): 945-952, 1990. [5.742] | |
| 111 | Ooi A, Nakanishi I, Sakamoto N, Tsukada Y, Takahashi Y, Minamoto T, Mai M. Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation? Cancer 65 (8): 1741-1747, 1990. [5.742] | |
| 112 | Okada Y, Katsuda S, Matsui Y, Minamoto T, Nakanishi I. Altered synthesis of collagen types in cultured arterial smooth muscle cells during phenotypic modulation by dimethyl sulfoxide. Act Pathol Jpn (Pathol Int) 39 (1): 15-22, 1989.[2.110] | |
| 113 | Oda Y, Kawahara E, Minamoto T, Ueda Y, Ikeda K, Nagai Y, Nakanishi I. Immuno-histochemical studies on the tissue localization of collagen types I, III, IV, V and VI in schwannomas. Correlation with ultrastructural features of the extracellular matrix. Virchows Arch B Cell Pathol 56 (3): 153-163, 1988. [2.906] | |
| 114 | Minamoto T, Ooi A, Okada Y, Mai M, Nagai Y, Nakanishi I. Desmoplastic reaction of gastric carcinoma: A light- and electron-microscopic immunohistochemical analysis using collagen type-specific antibodies. Hum Pathol 19 (7): 815-821, 1988. [3.466] |  |
| 115 | Katsuda S, Okada Y, Minamoto T, Nakanishi I. Enhanced synthesis of type IV collagen in cultured arterial smooth muscle cells associated with phenotypic modulation by dimethyl sulfoxide. Cell Biol Int 11 (12): 861-870, 1987. [3.612] | |
| 116 | Minamoto T, Arai K, Hirakawa S, Nagai Y. Immunohistochemical studies on collagen types in the uterine cervix in pregnant and nonpregnant states. Am J Obstet Gynecol 156 (1): 138-144, 1987. [6.502] |  |
| 117 | Nagai Y, Sunada H, Sano J, Onodera S, Arai K, Konomi H, Minamoto T, Hata R, Hori H, Nakanishi I, Kitaoka H, Sakamoto G. Biochemical and immunohisto-chemical studies on the scirrhous carcinoma of human stomach. Ann NY Acad Sci 460: 321-332, 1985. [5.691] | |
著書・総説
| 118 | Abe K*, Shimozaki S*, Domoto T, Yamamoto N, Tsuchiya H, Minamoto T. Glycogen synthase kinase 3β biology in bone and soft tissue sarcomas. J Cancer Metastasis Treat 6: 51, 2020. doi: 10.20517/2394-4722.2020.117 *equal contribution [2.010] |  |
|---|---|---|
| 119 | Domoto T, Uehara M, Bolidong D, Minamoto T. Glycogen synthase kinase 3β in cancer biology and treatment. Cells, 9(6):1388, 2020, doi:10.3390/cells.9061388. [6.600] | |
| 120 | Minamoto T. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions. Methods Mol Biol 2102:419-37, 2020. doi: 10.1007/978-1-0716-0223-2_24 [10.71] |  |
| 121 | Domoto T, Pyko IV, Furuta T, Miyashita K, Uehara M, Shimasaki T, Nakada M, Minamoto T. Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci. 2016 Aug 3. doi: 10.1111/cas.13028.[6.716] |  |
| 122 | Minamoto T. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions. Methods Mol Biol 1105: 381-98, 2014. doi: 10.1007/978-1-62703-739-6_29.[10.71] | |
| 123 | Shimasaki T, Kitano A, Motoo Y, Minamoto T. Aberrant glycogen synthase kinase 3β in pancreatic cancer development, progression and resistance to therapy. J Carcinog 11: 15, 2012.[11.000] |  |
| 124 | Nakada M, Furuta T, Hayashi Y, Minamoto T, Hamada JI. The strategy for enhancing temozolomide against malignant glioma. Front Oncol 2: 98, 2012.[6.244] |  |
| 125 | Minamoto T, Kotake M, Nakada M, Shimasaki T, Motoo Y, Kawakami K. Distinct pathologic role for glycogen synthase kinase 3β in colorectal cancer progression. In: Colorectal Cancer Biology - From Genes to Tumor, Rajunor Ettarh (Ed.), ISBN: 978-953-51-0062-1, pp. 107-134, 2012; InTech. |  |
| 126 | Nakada M, Minamoto T, Pyko IV, Hayashi Y, Hamada JI. The pivotal role of GSK3β in glioma biology. In: Molecular Targets of CNS Tumors, ISBN 978-953-307-736-9, Miklos Garami (Ed.), pp. 567-590, 2011; InTech. |  |
| 127 | Motoo Y, Shimasaki T, Ishigaki Y, Nakajima H, Kawakami K, Minamoto T. Metabolic disorder, inflammation and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies. Cancers 3 (1): 446-460, 2011.[6.639] |  |
| 128 | Nakada M, Kita D, Hayashi Y, Kawakami K, Hamada J, Minamoto T. RNAi in malignant brain tumors: relevance to molecular and translational research. In; Erdmann VA, Barciszewski J, eds., RNA Technologies and Their Applications, Springer Verlag, 2010, pp. 107-129. |  |
| 129 | Motoo Y, Shimasaki T, Minamoto T. Gemcitabine changes the gene expression in human pancreatic cancer cells: search for new therapeutic molecular targets. Iovanna J, Ismailov U, eds., Pancreatology, From Bench to Bedside, Springer Verlag, Berlin, Heidelberg, 2009, pp. 33-38. |  |
| 130 | Miyashita K, Nakada M, Shakoori A, Ishigaki Y, Shimasaki T, Motoo Y, Kawakami K, Minamoto T. An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3β. Anti-Cancer Agents Med Chem 9 (10): 1114-1122, 2009. [2.505] |  |
| 131 | Fuchs SY, Ougolkov AV, Spiegelman VS, Minamoto T. Oncogenic β-catenin signaling network in colorectal cancer. Cell Cycle 4 (11): 1520-1537, 2005. [4.534] |  |
| 132 | Minamoto T. Detection and characterization of oncogene mutations in preneoplastic and early neoplastic lesions: K-ras oncogene in non-neoplastic tissue and aberrant crypt foci of colorectal cancer patients. In; Keohavong P and Grant S, eds., Molecular Toxicology Protocols/Methods of Molecular Biology Vol. 291, Humana Press, Totawa, NJ, 2005, pp. 263-278.[10.71] | |
| 133 | Minamoto T, Ougolkov A Mai M. Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling. Expert Rev Mol Diag 2 (6): 89-99, 2002. [5.225] |  |
| 134 | Minamoto T, Ronai Z. Gene mutation as target for early detection in cancer diagnosis. Crit Rev Oncol Hematol 40 (3): 195-213, 2001. [6.312] |  |
| 135 | Ronai Z, Minamoto T. Early detection of gene mutation in cancer diagnosis. Princ Pract Oncol 15 (1): 1-16, 2001. | |
| 136 | Minamoto T, Mai M, Ronai Z. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas and lung cancers—a review. Cancer Detec Prev (Cancer Epidemiol) 24 (1): 1-12, 2000. [2.984] | |
| 137 | Minamoto T, Mai M, Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis 20 (4): 519-527, 1999. [4.944] |  |